Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Vadim D. Marchenko who wrote (198)	12/2/1997 3:33:00 PM
From: Jongmans	Respond to of 4474

A confirmation of ARIAD's scientific strength. Start of a period with a succession of good news!? Martin

To: Vadim D. Marchenko who wrote (198)	12/2/1997 4:36:00 PM
From: Dulane U. Ponder	Read Replies (1) \| Respond to of 4474

I am really convinced that signal transduction pathway "blockers" have great potential and especially via the oral route since i believe most small proteins presently available have to be administered IV. Continue to be greatly interested in this stock. My only concern is that the warrant shares I own will reach expiration before the stock itself moves up. Since I bought some warrant shares at a pretty good premium I hope there will be some good news for this company in early '98. When in '98 are clinical trials scheduled to begin?